As of June 2026, according to Cintas's current financial statements, the company's 12-month EPS is $4.8. For the year 2025, the company recorded an earnings per share (EPS) of $4.48, which marks an increase compared to its EPS of $3.85 in 2024. Cintas's earnings per share for the quarterly report ending on Feb 28, 2026 reached $1.25.
The annual EPS for the year 2025 was $4.48, an increase of 16.4% from $3.85 in 2024. For the fiscal quarter that ended on Feb 28, 2026, the per-share earnings was $1.25, showing a 9.6% increase from the same quarter last year. For the twelve months ending February 2026, the EPS is $4.8. For the year 2024, the yearly earnings per share was $3.85, marking an increase of 16.7% from 2023.
During the last 12 months, Cintas has seen an EPS growth of 9.6% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 14.6% per year. During the last 5 years, the company had an average EPS growth rate of 16.5%. When measured over a ten-year period, CTAS's average EPS growth rate was 17.2%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GNTX Gentex Corp | 14.16 | -1.7% | 8.6% | 4.3% |
| ABM Abm Industries Inc | 17.1 | 102.3% | -8.8% | N/A |
| HCSG Healthcare Services Group Inc | 23.81 | 51.9% | 21.3% | -9.1% |
| UNF Unifirst Corp | 33.99 | 2.7% | 13.4% | 2.2% |
| CTAS Cintas Corp | 35.21 | 16.4% | 14.6% | 16.5% |
| ARMK Aramark | 39.8 | 24% | 17.7% | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.